Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    n/a

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 1 year

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	Trend
Assets
Cash and Cash Equivalents	25.7%
Short Term Investments	0.0%
Accounts Receivable	21.4%
Inventory	14.8%
Prepaid Expenses	4.2%
Other Current Assets	4.2%
Total Current Assets	66.1%
Property,Plant and Equipment	29.1%
Operating Lease Assets	2.6%
Goodwill	64.4%
Intangible Assets	6.4%
Long Term Investments	1.9%
Other Noncurrent Assets	15.2%
Total Assets	183.2%
Liabilities
Accounts Payable	8.2%
Accrued Liabilities	6.4%
Deferred Revenue	9.0%
Current Portion of Long Term Debt	4.4%
Total Current Liabilities	33.8%
Long Term Debt	43.9%
Deferred Revenue Noncurrent	9.0%
Other Noncurrent Liabilities	6.7%
Total Liabilities	86.2%
Equity
Preferred Stock	0.0%
Common Stock	0.0%
Additional Paid In Capital	80.2%
Retained Earnings	20.0%
Treasury Stock	0.0%
Accumulated Other Comprehensive Income	-3.3%
Total Stockholders Equity	97.0%
Total Liabilitiesand Equity	183.2%

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	100.0%
Expenses Cost of Revenue	47.6%
Expenses Research and Development	6.5%
Expenses Selling,General and Administrative	24.6%
Expenses Depreciation and Amortization	4.1%
Expenses Share Based Compensation	1.8%
Expenses Restructuring and Asset Impairment	1.2%
Expenses Operating Expenses	78.7%
Other Income Expense Operating Income	21.3%
Other Income Expense Interest Income	0.9%
Other Income Expense Interest Expense	1.6%
Other Income Expense Other Income/expense	0.1%
Other Income Expense Income Before Tax	20.7%
Income Tax Income Tax Expense	1.9%
net Income net Income	18.8%
net Income Comprehensive Income	19.9%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Basic	4.1%
Earnings Per Share Weighted Average Shares Diluted	4.1%

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 1 year

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	Trend
CashFlow
Operating Activities net Income	18.8%
Operating Activities Depreciation and Amortization	4.1%
Operating Activities Stock Based Compensation	1.8%
Operating Activities Deferred Income Taxes	-1.9%
Operating Activities Changes In Operating Assets and Liabilities	12.0%
Operating Activities net Cash From Operating Activities	22.4%
Investing Activities Capital Expenditures	5.9%
Investing Activities Business Acquisitions	-0.1%
Investing Activities Purchases of Investments	0.0%
Investing Activities net Cash From Investing Activities	-5.7%
Financing Activities Proceeds From Debt	0.1%
Financing Activities Repayment of Debt	0.0%
Financing Activities Repurchase of Common Stock	6.1%
Financing Activities Dividends Paid	4.1%
Financing Activities Proceeds From Stock Issuance	1.0%
Financing Activities Tax Withholding On Stock Based Compensation	0.4%
Financing Activities Other Financing Activities	0.0%
Financing Activities net Cash From Financing Activities	-10.3%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%
Cash Reconciliation net Change In Cash	6.6%
Cash Reconciliation Cash At Beginning of Period	25.8%
Cash Reconciliation Cash At End of Period	25.8%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	+52.4%
Operating margin	+21.3%
Net margin	+18.8%
FCF margin	+16.6%
Growth
Revenue CAGR (3y)	+0.5%
Returns
ROE	+19.3%
ROA	+10.2%
ROIC	+16.2%
Liquidity
Current ratio	1.96x
Quick ratio	1.40x
Leverage
D/E	0.89x
Interest coverage	13.21x
Efficiency
Asset turnover	0.55x
Cash conversion cycle	+128d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched